Common Stock, Shares, Issued of ANAPTYSBIO, INC from Q4 2016 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
ANAPTYSBIO, INC quarterly Common Stock, Shares, Issued history and change rate from Q4 2016 to Q3 2025.
  • ANAPTYSBIO, INC Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 27.6M shares, a 9.38% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

ANAPTYSBIO, INC Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 27.6M -2.85M -9.38% 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 28M +539K +1.97% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 30.4M +3.07M +11.2% 31 Mar 2025 10-Q 05 May 2025
Q4 2024 30.5M +3.88M +14.6% 31 Dec 2024 10-Q 04 Nov 2025
Q3 2024 30.4M +3.85M +14.5% 30 Sep 2024 10-Q 05 Nov 2024
Q2 2024 27.4M +903K +3.41% 30 Jun 2024 10-Q 05 Aug 2024
Q1 2024 27.3M +298K +1.11% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 26.6M -1.92M -6.72% 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 26.6M -1.78M -6.27% 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 26.5M -1.7M -6.02% 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 27M -1.16M -4.12% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 28.5M +866K +3.13% 31 Dec 2022 10-K 11 Mar 2024
Q3 2022 28.4M +900K +3.28% 30 Sep 2022 10-Q 08 Nov 2022
Q2 2022 28.2M +799K +2.91% 30 Jun 2022 10-Q 08 Aug 2022
Q1 2022 28.2M +810K +2.96% 31 Mar 2022 10-Q 04 May 2022
Q4 2021 27.6M +291K +1.06% 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 27.5M +108K +0.39% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 27.4M +145K +0.53% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 27.4M +90.2K +0.33% 31 Mar 2021 10-Q 04 May 2021
Q4 2020 27.4M +101K +0.37% 31 Dec 2020 10-K 07 Mar 2022
Q3 2020 27.3M +248K +0.92% 30 Sep 2020 10-Q 04 Nov 2020
Q2 2020 27.3M +243K +0.9% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 27.3M +271K +1% 31 Mar 2020 10-Q 06 May 2020
Q4 2019 27.3M +333K +1.24% 31 Dec 2019 10-K 25 Feb 2021
Q3 2019 27.1M +349K +1.31% 30 Sep 2019 10-Q 08 Nov 2019
Q2 2019 27M +3.02M +12.6% 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 27M +3.19M +13.4% 31 Mar 2019 10-Q 07 May 2019
Q4 2018 26.9M +3.13M +13.2% 31 Dec 2018 10-K 02 Mar 2020
Q3 2018 26.7M +6.25M +30.5% 30 Sep 2018 10-Q 08 Nov 2018
Q2 2018 24M +3.74M +18.4% 30 Jun 2018 10-Q 07 Aug 2018
Q1 2018 23.8M +3.57M +17.6% 31 Mar 2018 10-Q 08 May 2018
Q4 2017 23.8M +21.1M +797% 31 Dec 2017 10-K 28 Feb 2019
Q3 2017 20.5M 30 Sep 2017 10-Q 07 Nov 2017
Q2 2017 20.3M 30 Jun 2017 10-Q 10 Aug 2017
Q1 2017 20.2M 31 Mar 2017 10-Q 12 May 2017
Q4 2016 2.65M 31 Dec 2016 10-K 05 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.